Comparison of the Effect of Rifaximin and Probiotic and Bismuth on the Treatment of Susceptible Colon.
Phase 3
- Conditions
- Irritable Bowel Syndrome.Irritable bowel syndrome
- Registration Number
- IRCT20190524043688N1
- Lead Sponsor
- Sanandaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
1. Abdominal pain or any digestive discomfort for at least 3 months and 3 times a month, during one year, these 3 months may be consecutive or non sequential.2. Comes with two of the following three cases: the relief of pain in the development of symptoms of the onset of symptoms, as well as changes in the frequency of atrial fibrillation, the onset of symptoms associated with stool deformity
Age 18 to 50 years
Exclusion Criteria
1.History of Celiac Disease 2.Lactase Deficiency 3.Thyroid Diseases 4.Organic intestinal Causes 5.Prohibition of Bismuth Consumption 6.Prohibition of using Rifaximine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method